This is a timely post for me. I have not been on Enzalutamide (so I’m not sure how much use this will be to you) but have been on Abiraterone and am facing a similar decision to Kevin.
I was diagnosed in 2022; PSA not very high (only 6.4 but an rapid increase from 9 years at 0.7 or so) but going through all the tests found Gleason 5 + 4, and spread into the lymph nodes in my rectum. 37 fractions of RT, Prostap 3 monthly, Abiraterone & Prednisolone daily. September 2025 will be 3 years of treatment and, as the treatment has worked so well Oncologist meeting in two weeks is discuss potentially coming off treatment (not sure yet if that is just Abi or both Abi and Prostap). Originally they said I’d be on ADT for life.
I have remained very active - ave 15k steps a day, cycle, golf, walking rugby, gym sessions; chair 3 charities, sit on 3 others, just taken over as High Sheriff but side effects have been quite bad especially muscle loss (legs in particular) and fatigue + some radiation damage to my rectum and bowel incontinence.
As first line treatment I could only have Abiraterone on Private Medical Insurance and my premium has gone through the roof.
I would love to give my body a break (and stop my PMI) but I’m concerned about what my options would be if/when I need treatment in the future on the NHS, how quickly I will be able to get it and how I will cope psychologically with constantly watching for PSA increases. I guess I will learn more at the meeting at which my sister-in-law (a retired GP) will be accompanying me again.
Good luck with your own decision.
Best
Ian